Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Aprea Therapeutics, Inc. | President, CEO, Director | Common Stock | 331K | $2.42M | $7.29 | Mar 28, 2024 | Direct |
Aprea Therapeutics, Inc. | President, CEO, Director | Common Stock | 1.2K | $8.75K | $7.29 | Mar 28, 2024 | By daughter |
Aprea Therapeutics, Inc. | President, CEO, Director | Common Stock | 600 | $4.37K | $7.29 | Mar 28, 2024 | By son |
Aprea Therapeutics, Inc. | President, CEO, Director | Stock Options (Right to Buy) | 26.9K | Mar 28, 2024 | Direct | ||
Aprea Therapeutics, Inc. | President, CEO, Director | Tranche A Warrant | 1K | Mar 13, 2024 | Direct | ||
Aprea Therapeutics, Inc. | President, CEO, Director | Tranche B Warrant | 1K | Mar 13, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
APRE | Aprea Therapeutics, Inc. | Mar 28, 2024 | 2 | $0 | 4 | Mar 28, 2024 | President, CEO, Director |
APRE | Aprea Therapeutics, Inc. | Mar 13, 2024 | 3 | $14.6K | 4 | Mar 14, 2024 | President, CEO, Director |
APRE | Aprea Therapeutics, Inc. | Aug 23, 2022 | 4 | $0 | 4 | Mar 13, 2023 | President, CEO, Director |
APRE | Aprea Therapeutics, Inc. | Jul 28, 2022 | 2 | $0 | 4 | Aug 1, 2022 | President, CEO |
APRE | Aprea Therapeutics, Inc. | May 16, 2022 | 0 | $0 | 3 | May 26, 2022 | President, Director |